Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: CRO governance models

CRO Oversight and Management in Clinical Trials: Best Practices for Sponsor Collaboration and Compliance

Posted on May 13, 2025 digi By digi

CRO Oversight and Management in Clinical Trials: Best Practices for Sponsor Collaboration and Compliance Foundations and Best Practices for Effective CRO Oversight and Management in Clinical Trials While outsourcing clinical trial activities to Contract Research Organizations (CROs) provides sponsors with operational flexibility and scalability, regulatory agencies make it clear that sponsors retain ultimate responsibility for…

Read More “CRO Oversight and Management in Clinical Trials: Best Practices for Sponsor Collaboration and Compliance” »

Contract Research Organizations (CROs), CRO Oversight and Management

CRO Selection Criteria for Clinical Trials: How to Choose the Right Research Partner

Posted on May 3, 2025 digi By digi

CRO Selection Criteria for Clinical Trials: How to Choose the Right Research Partner Critical Insights into Selecting the Right CRO for Clinical Trials Choosing the right Contract Research Organization (CRO) is one of the most strategic decisions a sponsor can make when outsourcing clinical trials. A well-matched CRO partnership accelerates timelines, improves data quality, ensures…

Read More “CRO Selection Criteria for Clinical Trials: How to Choose the Right Research Partner” »

Contract Research Organizations (CROs), CRO Selection Criteria

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
  • Clinical Trial Design and Protocol Development
  • Good Clinical Practice (GCP) and Compliance
  • U.S. FDA Regulations

Menu

Recent Posts

  • Adaptive Designs in Phase 2: Interim Analyses and Seamless Designs
  • Endpoint Selection in Phase 3 Trials: Understanding Primary and Secondary Endpoints
  • Dose Escalation Designs in Phase 1: 3+3, BOIN, mTPI, CRM Explained
  • Randomized Controlled Phase 2 Trials: Pros and Cons
  • Comparative Effectiveness Research in Phase 4 Clinical Trials: Real-World Value Assessment

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme